ES8801121A1 - Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. - Google Patents

Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.

Info

Publication number
ES8801121A1
ES8801121A1 ES552145A ES552145A ES8801121A1 ES 8801121 A1 ES8801121 A1 ES 8801121A1 ES 552145 A ES552145 A ES 552145A ES 552145 A ES552145 A ES 552145A ES 8801121 A1 ES8801121 A1 ES 8801121A1
Authority
ES
Spain
Prior art keywords
potassium chloride
controlled release
coated
micro pellets
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552145A
Other languages
English (en)
Other versions
ES552145A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Key Pharmaceuticals Inc
Original Assignee
Key Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharmaceuticals Inc filed Critical Key Pharmaceuticals Inc
Publication of ES552145A0 publication Critical patent/ES552145A0/es
Publication of ES8801121A1 publication Critical patent/ES8801121A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)

Abstract

METODO DE FABRICAR UNA UNIDAD DE DOSIFICACION PARA LA ADMINISTRACION ORAL DE CLORURO POTASICO. CONSISTE EN: A) PREPARAR UNA SOLUCION DE REVESTIMIENTO POR DISOLUCION DE ETILCELULOSA E HIDROXIPROPILCELULOSA O POLIETILENGLICOL EN UN DISOLVENTE O SISTEMA DISOLVENTE; B) REVESTIR CRISTALES DE CLORURO POTASICO POR REVESTIMIENTO EN LECHO FLUIDO, A TEMPERATURA PROXIMA A LOS 60JC Y BAJO UNA PRESION DE 1,5 BARES; Y C) COMPRIMIR LOS CRISTALES REVESTIDOS, EN PRESENCIA DE AUXILIARES DE COMPRESION Y AGENTES DESINTEGRANTES. TIENE APLICACIONES FARMACOLOGICAS.
ES552145A 1985-02-19 1986-02-18 Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico. Expired ES8801121A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70271485A 1985-02-19 1985-02-19

Publications (2)

Publication Number Publication Date
ES552145A0 ES552145A0 (es) 1988-01-01
ES8801121A1 true ES8801121A1 (es) 1988-01-01

Family

ID=24822313

Family Applications (1)

Application Number Title Priority Date Filing Date
ES552145A Expired ES8801121A1 (es) 1985-02-19 1986-02-18 Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.

Country Status (13)

Country Link
EP (1) EP0211946B1 (es)
JP (1) JPH0625064B2 (es)
AU (1) AU583903B2 (es)
DE (1) DE3671373D1 (es)
DK (1) DK165123C (es)
ES (1) ES8801121A1 (es)
FI (1) FI87528C (es)
GR (1) GR860479B (es)
IE (1) IE59066B1 (es)
NZ (1) NZ215241A (es)
SG (1) SG120392G (es)
WO (1) WO1986004817A1 (es)
ZA (1) ZA861242B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
DE69107461T2 (de) * 1990-08-07 1995-06-22 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US5397574A (en) * 1993-10-04 1995-03-14 Andrx Pharmaceuticals, Inc. Controlled release potassium dosage form
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
AU3024399A (en) 1998-04-03 1999-10-25 Bm Research A/S Controlled release composition
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
EP1429739A1 (en) 2001-09-21 2004-06-23 Egalet A/S Polymer release system
AU2003275953A1 (en) 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
EP1610768B1 (en) 2003-03-26 2008-07-02 Egalet A/S Matrix compositions for controlled delivery of drug substances
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations
US9549899B2 (en) 2012-07-06 2017-01-24 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
DE3170764D1 (en) * 1980-11-12 1985-07-04 Ciba Geigy Ag Fast disaggregating pharmaceutical tablet
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.

Also Published As

Publication number Publication date
EP0211946A1 (en) 1987-03-04
JPH0625064B2 (ja) 1994-04-06
ZA861242B (en) 1986-10-29
NZ215241A (en) 1988-10-28
IE59066B1 (en) 1993-12-15
FI87528B (fi) 1992-10-15
AU583903B2 (en) 1989-05-11
ES552145A0 (es) 1988-01-01
FI87528C (fi) 1993-01-25
IE860433L (en) 1986-08-19
WO1986004817A1 (en) 1986-08-28
FI864207A0 (fi) 1986-10-17
EP0211946B1 (en) 1990-05-23
DK494986D0 (da) 1986-10-16
AU5514086A (en) 1986-09-10
DK165123C (da) 1993-03-01
FI864207L (fi) 1986-10-17
DK494986A (da) 1986-10-16
DE3671373D1 (de) 1990-06-28
GR860479B (en) 1986-06-18
JPS62501845A (ja) 1987-07-23
SG120392G (en) 1993-01-29

Similar Documents

Publication Publication Date Title
FI864207L (fi) Kontrollerad frigivning av kaliumklorid.
CA1240925A (en) Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
NZ231281A (en) Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol
ES8104911A1 (es) Procedimiento para preparar una composicion terapeutica de liberacion retardada, conformada y comprimida, que contiene una sustancia terapeuticamente activa incorporada en un ma- terial excipiente de hidroxipropilmetilcelulosa
IE873213L (en) Galenical Formulation
IL111519A (en) Sustained release tablets containing acetaminophen and methods for the preparation thereof
MY104898A (en) Modified release gemfibrozil composition
CA2417686A1 (en) Manufacture of oral dosage forms delivering both immediate release and sustained release drugs
CA2094030A1 (en) A method for drug formulation and a pharmaceutical composition
ATE30380T1 (de) Pharmazeutische formulierungen mit mehrfachen einheiten.
JPH0791183B2 (ja) ヒドロキシプロピルメチルセルロースとアルカリ金属カルボキシレートとを含有する持続的解放薬物投薬組成物
GB1465781A (en) Pharmaceutical preparations
MY104010A (en) Pharmaceutical compositions.
JPH01100125A (ja) エブセレンの超微結晶を含む固体医薬製剤
EP0804172A4 (es)
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
US5922342A (en) Lateral edge coated controlled release pharmaceutical compositions
JPS61118317A (ja) 圧縮コーテイングした分散し得る錠剤
EP0551292B1 (en) Lateral edge coated controlled release pharmaceutical compositions
MY100956A (en) Controlled release potassium chloride.
NZ514322A (en) Particle based vaccine composition
JPS6471823A (en) Sustained remedy for vaginal candidiasis
UA80872C2 (uk) Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення
ES531346A0 (es) Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph
JPS5549312A (en) Preparation of slow-releasing medicine

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040929